A detailed history of Rtw Investments, LP transactions in Exagen Inc. stock. As of the latest transaction made, Rtw Investments, LP holds 1,504,602 shares of XGN stock, worth $2.74 Million. This represents 0.04% of its overall portfolio holdings.

Number of Shares
1,504,602
Previous 1,504,602 -0.0%
Holding current value
$2.74 Million
Previous $2.99 Million 20.11%
% of portfolio
0.04%
Previous 0.05%

Shares

14 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2023

Feb 14, 2024

BUY
$1.45 - $2.39 $17,646 - $29,086
12,170 Added 0.82%
1,504,602 $2.99 Million
Q2 2023

Aug 14, 2023

BUY
$2.36 - $3.48 $238,945 - $352,343
101,248 Added 7.28%
1,492,432 $4.33 Million
Q1 2023

May 15, 2023

BUY
$2.23 - $2.9 $59,871 - $77,859
26,848 Added 1.97%
1,391,184 $3.38 Million
Q4 2022

Feb 14, 2023

BUY
$2.1 - $3.4 $662,915 - $1.07 Million
315,674 Added 30.1%
1,364,336 $3.27 Million
Q3 2022

Nov 14, 2022

BUY
$3.43 - $8.68 $81,153 - $205,368
23,660 Added 2.31%
1,048,662 $2.84 Million
Q2 2022

Aug 15, 2022

BUY
$4.18 - $7.74 $145,710 - $269,808
34,859 Added 3.52%
1,025,002 $5.88 Million
Q1 2022

May 16, 2022

BUY
$7.12 - $11.06 $1.2 Million - $1.87 Million
168,729 Added 20.54%
990,143 $7.95 Million
Q2 2021

Aug 13, 2021

SELL
$12.4 - $17.92 $9.98 Million - $14.4 Million
-804,951 Reduced 49.49%
821,414 $12.3 Million
Q1 2021

May 14, 2021

BUY
$13.9 - $22.0 $5.23 Million - $8.28 Million
376,234 Added 30.1%
1,626,365 $28.5 Million
Q3 2020

Nov 16, 2020

SELL
$10.56 - $16.69 $52,800 - $83,450
-5,000 Reduced 0.4%
1,250,131 $13.6 Million
Q2 2020

Aug 14, 2020

SELL
$11.0 - $16.7 $5,599 - $8,500
-509 Reduced 0.04%
1,255,131 $15.6 Million
Q1 2020

May 15, 2020

BUY
$12.7 - $25.95 $6.82 Million - $13.9 Million
536,694 Added 74.65%
1,255,640 $20 Million
Q4 2019

Feb 14, 2020

BUY
$12.61 - $28.48 $2.61 Million - $5.9 Million
207,313 Added 40.52%
718,946 $18.3 Million
Q3 2019

Nov 14, 2019

BUY
$14.5 - $17.5 $7.42 Million - $8.95 Million
511,633 New
511,633 $7.93 Million

Others Institutions Holding XGN

About EXAGEN INC.


  • Ticker XGN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 16,260,400
  • Market Cap $29.6M
  • Description
  • Exagen Inc. develops and commercializes various testing products based on its cell-bound complement activation products technology under the AVISE brand in the United States. It enables rheumatologists to care for patients through the diagnosis, prognosis, and monitoring of autoimmune and autoimmune-related diseases, including systemic lupus ery...
More about XGN
Track This Portfolio

Track Rtw Investments, LP Portfolio

Follow Rtw Investments, LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Rtw Investments, LP, based on Form 13F filings with the SEC.

News

Stay updated on Rtw Investments, LP with notifications on news.